Efficient nano-enabled therapy for gastrointestinal cancer using silicasome delivery technology

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Science China Chemistry

• Publication date

  2021-10-18

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s11426-021-1126-x
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimized polyepitope neoantigen DNA vaccines elicit neoantigen-specific immune responses in preclinical models and in clinical translation

  2021cited by this paper
• Two nanoformulations induce reactive oxygen species and immunogenetic cell death for synergistic chemo-immunotherapy eradicating colorectal cancer and hepatocellular carcinoma

  2021cited by this paper
• Consideration for the scale‐up manufacture of nanotherapeutics—A critical step for technology transfer

  2021cited by this paper
• Tailor‐Made Nanomaterials for Diagnosis and Therapy of Pancreatic Ductal Adenocarcinoma

  2021cited by this paper
• Combination Chemo‐Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti‐PD‐1

  2021cited by this paper
• Development of Facile and Versatile Platinum Drug Delivering Silicasome Nanocarriers for Efficient Pancreatic Cancer Chemo-Immunotherapy.

  2021cited by this paper
• Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment

  2020cited by this paper
• Combination of tumour-infarction therapy and chemotherapy via the co-delivery of doxorubicin and thrombin encapsulated in tumour-targeted nanoparticles

  2020cited by this paper
• Immune checkpoint inhibition in syngeneic mouse cancer models by a silicasome nanocarrier delivering a GSK3 inhibitor.

  2020cited by this paper
• Detection of immunogenic cell death and its relevance for cancer therapy

  2020cited by this paper
• Liposomal Delivery of Mitoxantrone and a Cholesteryl Indoximod Prodrug Provides Effective Chemo-Immunotherapy in Multiple Solid Tumors.

  2020cited by this paper
• Tailored Chemodynamic Nanomedicine Improves Pancreatic Cancer Treatment via Controllable Damaging Neoplastic Cells and Reprogramming Tumor Microenvironment.

  2020cited by this paper
• Cancer-associated fibroblasts in gastrointestinal cancer

  2019cited by this paper
• Development of self-assembled multi-arm polyrotaxanes nanocarriers for systemic plasmid delivery in vivo.

  2019cited by this paper
• Sheddable Prodrug Vesicles Combating Adaptive Immune Resistance for Improved Photodynamic Immunotherapy of Cancer.

  2019cited by this paper
• Nanoformulated Codelivery of Quercetin and Alantolactone Promotes an Antitumor Response through Synergistic Immunogenic Cell Death for Microsatellite-Stable Colorectal Cancer.

  2019cited by this paper
• Transcytosis - An effective targeting strategy that is complementary to “EPR effect” for pancreatic cancer nano drug delivery

  2019cited by this paper
• Molecular Markers for Treatment Response and Toxicity of Gemcitabine

  2019cited by this paper
• Inorganic Nanoshell-Stabilized Liquid Metal for Targeted Photonanomedicine in NIR-II Biowindow.

  2019cited by this paper
• In Situ Dendritic Cell Vaccine for Effective Cancer Immunotherapy.

  2019cited by this paper
• Animal models for modeling pancreatic cancer and novel drug discovery

  2019cited by this paper
• Use of nano engineered approaches to overcome the stromal barrier in pancreatic cancer.

  2018cited by this paper
• Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer.

  2018cited by this paper
• Complex silica composite nanomaterials templated with DNA origami

  2018cited by this paper
• Magnesium-Engineered Silica Framework for pH-Accelerated Biodegradation and DNAzyme-Triggered Chemotherapy.

  2018cited by this paper
• Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer.

  2018cited by this paper
• Improved Efficacy and Reduced Toxicity Using a Custom-Designed Irinotecan-Delivering Silicasome for Orthotopic Colon Cancer.

  2018cited by this paper
• Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer

  2017cited by this paper
• Tumor-penetrating peptide enhances transcytosis of silicasome-based chemotherapy for pancreatic cancer

  2017cited by this paper
• PEPCOL: a GERCOR randomized phase II study of nanoliposomal irinotecan PEP02 (MM‐398) or irinotecan with leucovorin/5‐fluorouracil as second‐line therapy in metastatic colorectal cancer

  2016cited by this paper
• mRNA Cancer Vaccines.

  2016cited by this paper
• Irinotecan Delivery by Lipid-Coated Mesoporous Silica Nanoparticles Shows Improved Efficacy and Safety over Liposomes for Pancreatic Cancer.

  2016cited by this paper
• FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis.

  2016cited by this paper
• Pancreatic cancer

  2016cited by this paper
• Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism

  2016cited by this paper
• Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth.

  2016cited by this paper
• ACG Clinical Guideline: Genetic Testing and Management of Hereditary Gastrointestinal Cancer Syndromes

  2015cited by this paper
• A magnetic mesoporous silica nanoparticle-based drug delivery system for photosensitive cooperative treatment of cancer with a mesopore-capping agent and mesopore-loaded drug.

  2013cited by this paper
• Immunogenic cell death in cancer therapy.

  2013cited by this paper
• Mesoporous silica nanoparticles: A multifunctional nano therapeutic system.

  2013cited by this paper
• nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer.

  2012cited by this paper
• Processing pathway dependence of amorphous silica nanoparticle toxicity: colloidal vs pyrolytic.

  2012cited by this paper
• The role of stroma in pancreatic cancer: diagnostic and therapeutic implications

  2012cited by this paper
• Development of Pharmaceutically Adapted Mesoporous Silica Nanoparticles Platform.

  2012cited by this paper
• The Targeted Delivery of Multicomponent Cargos to Cancer Cells via Nanoporous Particle-Supported Lipid Bilayers

  2011cited by this paper
• Autonomous in vitro anticancer drug release from mesoporous silica nanoparticles by pH-sensitive nanovalves.

  2010cited by this paper
• Bio-degradation study of colloidal mesoporous silica nanoparticles: Effect of surface functionalization with organo-silanes and poly(ethylene glycol)

  2010cited by this paper
• Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles.

  2010cited by this paper
• Novel PET Probes Specific for Deoxycytidine Kinase

  2010cited by this paper
• The spindle-assembly checkpoint, aneuploidy, and gastrointestinal cancer.

  2010cited by this paper
• Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs.

  2009cited by this paper
• Molecular origins of cancer: Molecular basis of colorectal cancer.

  2009cited by this paper
• Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.

  2007cited by this paper
• The formation of supported lipid bilayers on silica nanoparticles revealed by cryoelectron microscopy.

  2005cited by this paper
• Supported membranes on soft polymer cushions: fabrication, characterization and applications.

  2000cited by this paper
• Physical properties of single phospholipid bilayers adsorbed to micro glass beads. A new vesicular model system studied by 2H-nuclear magnetic resonance.

  1990cited by this paper

• Silicasomes in Oncology: From Conventional Chemotherapy to Combined Immunotherapy

  2025cites this paper
• Development of Akkermansia Muciniphila Membrane‐Coated Mesoporous Silica Nanoparticles with a Cerium Oxide Core for Inflammatory Bowel Disease Treatment

  2025cites this paper
• Unlocking tumor barrier: annexin A2-mediated transcytosis boosts drug delivery in pancreatic and breast tumors

  2025cites this paper
• Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies

  2025cites this paper
• Engineered Design of a Mesoporous Silica Nanoparticle-Based Nanocarrier for Efficient mRNA Delivery in Vivo.

  2023cites this paper
• Amplified Fenton-Based Oxidative Stress Utilizing Ultraviolet Upconversion Luminescence-Fueled Nanoreactors for Apoptosis-Strengthened Ferroptosis Anticancer Therapy.

  2022cites this paper
• Mesoporous Silica Nanoparticle-Based Drug Delivery Systems for the Treatment of Pancreatic Cancer: A Systematic Literature Overview

  2022cites this paper